🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 8

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 8 of 20
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Jul 26, 2024 at 3:31 AM#36
Dr.PulmRoch said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

I read this differently from Dr.PulmRoch, on substance rather than tone. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

14 12labquiet_amy, emily_PDX, Dr.SleepRoch and 11 others
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Aug 3, 2024 at 3:09 PM#37
Dr.PulmRoch said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

15 13maya_sedona, stefan_berlin, Dr.EM_Chicago and 12 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Aug 12, 2024 at 2:43 AM#38
Dr.PulmRoch said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

16 14MikeFit_NJ, InsuranceTom, WendyG_ATL and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Aug 20, 2024 at 2:12 PM#39

From the other side of the consultation, briefly. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

17 15DoseLogDan, SleepFixSam, PurityPaulOR and 14 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Aug 29, 2024 at 1:36 AM#40
TrialNerd_Beth said:
Worth answering the question that was asked rather than the one behind it.

This matches mine closely enough to be worth saying so out loud.

39 12SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 36 others
Reply Quote Save Share Report
167891020

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register